Efficient genome editing in the mouse brain by local delivery of engineered Cas9 ribonucleoprotein complexes
- PMID: 28191903
- PMCID: PMC6649674
- DOI: 10.1038/nbt.3806
Efficient genome editing in the mouse brain by local delivery of engineered Cas9 ribonucleoprotein complexes
Abstract
We demonstrate editing of post-mitotic neurons in the adult mouse brain following injection of Cas9 ribonucleoprotein (RNP) complexes in the hippocampus, striatum and cortex. Engineered variants of Cas9 with multiple SV40 nuclear localization sequences enabled a tenfold increase in the efficiency of neuronal editing in vivo. These advances indicate the potential of genome editing in the brain to correct or inactivate the underlying genetic causes of neurological diseases.
Conflict of interest statement
Competing financial interests
The authors have submitted a patent disclosure on this work. J.A.D is employed by HHMI and works at the University at California Berkeley. UC Berkeley and HHMI have patents pending for CRISPR technologies on which she is an inventor. J.A.D is the executive director of the Innovative Genomics Institute at UC Berkeley and UCSF. J.A.D is a co-founder of Editas Medicine, Intellia Therapeutics and Caribou Biosciences and a scientific advisor to Caribou, Intellia, eFFECTOR Therapeutics and Driver.
Figures
References
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
